Atlas Trials

Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds

Clinical trial NCT03436160 · COMPLETED

Trial details

NCT number
NCT03436160
Sponsor
U.S. Army Medical Research and Development Command
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2018-08-10
Primary completion
2018-11-03
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.